Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPTOMYCIN for Endocarditis staphylococcal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 150 adverse event reports in the FDA FAERS database where DAPTOMYCIN was used for Endocarditis staphylococcal.

Most Reported Side Effects for DAPTOMYCIN

Side Effect Reports % Deaths Hosp.
Off label use 791 8.8% 123 360
Drug ineffective 658 7.3% 212 329
Product use in unapproved indication 654 7.2% 29 152
Eosinophilic pneumonia 575 6.4% 78 349
Acute kidney injury 501 5.6% 81 351
Blood creatine phosphokinase increased 461 5.1% 25 205
Pyrexia 447 5.0% 28 277
Eosinophilia 405 4.5% 35 288
Rhabdomyolysis 383 4.2% 26 264
Drug reaction with eosinophilia and systemic symptoms 307 3.4% 26 198
Chills 288 3.2% 1 75
Rash 288 3.2% 22 146
Interstitial lung disease 280 3.1% 40 196
Thrombocytopenia 242 2.7% 66 176
Pneumonitis 216 2.4% 18 121

Other Indications for DAPTOMYCIN

Staphylococcal infection (1,014) Product used for unknown indication (859) Osteomyelitis (635) Infection (613) Staphylococcal bacteraemia (511) Endocarditis (506) Enterococcal infection (416) Device related infection (405) Bacteraemia (380) Sepsis (298)

Other Drugs Used for Endocarditis staphylococcal

VANCOMYCIN (137) RIFAMPIN (72) GENTAMICIN (48) LINEZOLID (41) CEFAZOLIN (30) OXACILLIN (21) LEVOFLOXACIN (20) CUBICIN (19) CEFTAROLINE FOSAMIL (18) CEFTAROLINE (16)

Related Pages

DAPTOMYCIN Full Profile All Endocarditis staphylococcal Drugs DAPTOMYCIN Demographics DAPTOMYCIN Timeline